|
|
response to testosterone
|
GO:0033574 |
3 |
0.999
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.989
|
Mouse |
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.987
|
Mouse |
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.979
|
Mouse |
|
|
response to peptide
|
GO:1901652 |
136 |
0.971
|
Mouse |
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.952
|
Mouse |
|
|
response to vitamin d
|
GO:0033280 |
3 |
0.939
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.936
|
Mouse |
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.932
|
Mouse |
|
|
insulin secretion
|
GO:0030073 |
89 |
0.929
|
Mouse |
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.892
|
Mouse |
|
|
osteoblast development
|
GO:0002076 |
17 |
0.889
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.881
|
Mouse |
|
|
response to insulin
|
GO:0032868 |
100 |
0.877
|
Mouse |
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.875
|
Mouse |
|
|
pancreas development
|
GO:0031016 |
57 |
0.866
|
Mouse |
|
|
positive regulation of intracellular estrogen receptor signaling pathway
|
GO:0033148 |
4 |
0.853
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.826
|
Mouse |
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.813
|
Mouse |
|
|
cellular response to vitamin
|
GO:0071295 |
2 |
0.807
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.803
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.796
|
Mouse |
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.790
|
Mouse |
|
|
odontogenesis
|
GO:0042476 |
78 |
0.782
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.774
|
Mouse |
|
|
cell aging
|
GO:0007569 |
35 |
0.771
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.770
|
Mouse |
|
|
cellular response to vitamin d
|
GO:0071305 |
2 |
0.754
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.752
|
Mouse |
|
|
response to alcohol
|
GO:0097305 |
48 |
0.737
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.722
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.716
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.708
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.702
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.672
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.657
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.650
|
|
|
|
cellular water homeostasis
|
GO:0009992 |
2 |
0.646
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.645
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.643
|
Mouse |
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.637
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.621
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.610
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.578
|
|
|
|
spermatogenesis exchange of chromosomal proteins
|
GO:0035093 |
4 |
0.575
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.524
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.522
|
Mouse |
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.521
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.519
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.513
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.496
|
Mouse |
|
|
response to estrogen
|
GO:0043627 |
24 |
0.493
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.476
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.459
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.453
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.433
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.423
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.421
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.412
|
|
|
|
regulation of steroid hormone biosynthetic process
|
GO:0090030 |
4 |
0.396
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.395
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.383
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.372
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.371
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.368
|
Mouse |
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.358
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.353
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.347
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.345
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.345
|
Mouse |
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.340
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.333
|
Mouse |
|
|
chromatin organization
|
GO:0006325 |
206 |
0.319
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.313
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.310
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.308
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
11 |
0.308
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.302
|
|
|
|
response to ethanol
|
GO:0045471 |
18 |
0.298
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.298
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.293
|
|
|
|
positive regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033145 |
4 |
0.293
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.283
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.281
|
Mouse |
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.280
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.279
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.278
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.275
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.275
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.275
|
Mouse |
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.274
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.274
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.269
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.264
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.261
|
|
|
|
response to ketone
|
GO:1901654 |
15 |
0.258
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.251
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.243
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.240
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.239
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.235
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.235
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.234
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.233
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.233
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.224
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.223
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.220
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.218
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.217
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.216
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.216
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.213
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.213
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.213
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.213
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.212
|
|
|
|
cellular response to alcohol
|
GO:0097306 |
23 |
0.212
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.212
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.211
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.207
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.206
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.203
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.199
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.198
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.191
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.191
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.190
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.189
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.187
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.187
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.187
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.186
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.185
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.183
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.181
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.180
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
18 |
0.180
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.180
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.179
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.178
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.177
|
|
|
|
response to zinc ion
|
GO:0010043 |
5 |
0.177
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.175
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.175
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.171
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.171
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.168
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.164
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.164
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.162
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.161
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.160
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.160
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.157
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.153
|
|
|
|
response to vitamin
|
GO:0033273 |
6 |
0.152
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.151
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.151
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.149
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.149
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.148
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.146
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.145
|
|
|
|
response to activity
|
GO:0014823 |
13 |
0.145
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.144
|
Mouse |
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.143
|
Mouse |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.142
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.142
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.142
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.141
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.141
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.139
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.138
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.138
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.136
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.135
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.134
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.134
|
|
|
|
positive regulation of inositol trisphosphate biosynthetic process
|
GO:0032962 |
2 |
0.133
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.133
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.130
|
Mouse |
|
|
response to nutrient
|
GO:0007584 |
12 |
0.129
|
|
|
|
hormone biosynthetic process
|
GO:0042446 |
16 |
0.129
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.129
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.127
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.126
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.126
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.125
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.125
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.125
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.122
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.122
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.122
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.122
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.118
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.117
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.115
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.114
|
|
|
|
norepinephrine epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001994 |
3 |
0.114
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.114
|
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
3 |
0.112
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.111
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.109
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.108
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.108
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.105
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.104
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
19 |
0.104
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.103
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.103
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.102
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.101
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.101
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.100
|
|
|
|
negative regulation of hormone secretion
|
GO:0046888 |
20 |
0.099
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.098
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.098
|
|
|
|
positive regulation of atp catabolic process
|
GO:1903291 |
3 |
0.098
|
|
|
|
inositol trisphosphate metabolic process
|
GO:0032957 |
5 |
0.098
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.097
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.097
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.097
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.096
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.096
|
Mouse |
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.095
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.095
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.095
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.095
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.095
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.094
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.093
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.093
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.093
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.092
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.092
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.092
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.091
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.091
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.091
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.089
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.089
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.088
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.088
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.086
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.086
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.086
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.085
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.085
|
|
|
|
negative regulation of bone remodeling
|
GO:0046851 |
6 |
0.085
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.085
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.085
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.084
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.084
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.084
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.083
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.083
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.082
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.082
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.081
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.081
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.080
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.080
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.079
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.079
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.079
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.078
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.078
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.077
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.076
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.076
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.076
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.075
|
|
|
|
inositol phosphate biosynthetic process
|
GO:0032958 |
6 |
0.075
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.075
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.074
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.073
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.073
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.073
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.072
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.072
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.072
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.071
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.070
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.070
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.070
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.069
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.068
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.068
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.068
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.066
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.066
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.066
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.065
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.064
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.064
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.064
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.064
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.064
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.064
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.063
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.063
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.063
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.062
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.062
|
Mouse |
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.062
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.062
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.062
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.062
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.061
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.061
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.060
|
|
|
|
acetate ester metabolic process
|
GO:1900619 |
3 |
0.060
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.059
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.059
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.059
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.058
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.058
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.057
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.057
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.057
|
Mouse |
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.057
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.056
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.056
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.056
|
|
|
|
canonical wnt signaling pathway involved in metanephric kidney development
|
GO:0061290 |
2 |
0.056
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.055
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.055
|
|
|
|
negative regulation of insulin secretion
|
GO:0046676 |
14 |
0.055
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.055
|
|
|
|
cellular response to nutrient
|
GO:0031670 |
7 |
0.055
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.055
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.055
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.054
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.054
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.053
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.053
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.052
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.052
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.051
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.051
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.051
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.051
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.051
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.051
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.051
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.051
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.050
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.050
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.050
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.050
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.050
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.049
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.049
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.049
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.049
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.049
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.049
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.049
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.049
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.049
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.048
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.048
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.048
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.048
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.048
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.048
|
|
|
|
prostate gland growth
|
GO:0060736 |
13 |
0.048
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.048
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.047
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.047
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.047
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.047
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.047
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.047
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.047
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.047
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.046
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.046
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.046
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.046
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.046
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.046
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.046
|
|
|
|
regulation of glucose transport
|
GO:0010827 |
32 |
0.046
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.046
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.046
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.046
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.045
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.045
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.045
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.045
|
|
|
|
regulation of alcohol biosynthetic process
|
GO:1902930 |
16 |
0.045
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.045
|
|
|
|
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure
|
GO:0001985 |
1 |
0.045
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.044
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.044
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.044
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.044
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.044
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.044
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.044
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.044
|
|
|
|
seminiferous tubule development
|
GO:0072520 |
14 |
0.044
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.044
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.043
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.043
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.043
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.043
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.043
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.043
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.043
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.043
|
|
|
|
sertoli cell proliferation
|
GO:0060011 |
5 |
0.043
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.043
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.042
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.042
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.042
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.042
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.042
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.042
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.042
|
|
|
|
acetylcholine metabolic process
|
GO:0008291 |
3 |
0.042
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.041
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.041
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.041
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.041
|
|
|
|
negative regulation of peptide secretion
|
GO:0002792 |
16 |
0.041
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.041
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.041
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.040
|
|
|
|
basement membrane organization
|
GO:0071711 |
8 |
0.040
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.040
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.040
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.040
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.040
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.040
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.040
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.040
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.039
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.039
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.039
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.039
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.039
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.039
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.039
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.038
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.038
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.038
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.038
|
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.038
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.038
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.038
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.038
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.038
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.038
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.038
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.038
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.037
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.037
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.037
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.037
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.037
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.037
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.037
|
|
|
|
regulation of inositol phosphate biosynthetic process
|
GO:0010919 |
3 |
0.037
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.036
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.036
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.036
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.036
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.036
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.036
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.036
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.035
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.035
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.035
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.035
|
|
|
|
negative regulation of bone resorption
|
GO:0045779 |
6 |
0.035
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
16 |
0.035
|
|
|
|
creatine metabolic process
|
GO:0006600 |
4 |
0.035
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.034
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.034
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.034
|
|
|
|
protein targeting to vacuole
|
GO:0006623 |
3 |
0.034
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.034
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.034
|
|
|
|
male anatomical structure morphogenesis
|
GO:0090598 |
4 |
0.034
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.034
|
|
